Mathai Mammen Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mathai Mammen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mathai Mammen. Mathai Mammen is a Senior VP, Research in Innoviva, Inc. ($THRX) and a SVP, Research & Early Clin Dev in Innoviva, Inc. ($THRX) and a SVP, Research & Development in Theravance Biopharma, Inc. ($TBPH) and a Director in 10x Genomics, Inc. ($TXG).
Address: THERAVANCE, INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO 94080 CA
Companies in which Mathai Mammen is an Insider
10x Genomics, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Mathai Mammen: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Innoviva, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mathai Mammen: SVP, Research & Early Clin Dev, Senior VP, Research
Holdings: 308,936 shares
Latest Transaction: Jun 04 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mathai Mammen: SVP, Research & Development
Holdings: 288,111 shares
Current Value: $8,816,197
Latest Transaction: Mar 17 2016
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mathai Mammen
Sentiment: All, TXG, THRX, TBPH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2020 | TXG | 10x Genomics, Inc. | Mammen Mathai | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | Mammen Mathai | Director | Option Exercise | J | 1.16 | 200,000 | 232,000 | 200,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | Mammen Mathai | Director | Option Exercise | J | 1.16 | 200,000 | 232,000 | 0 | |
| Mar 17 2016 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Grant | A | 0.00 | 90,000 | 0 | 288,111 | 198.1 K to 288.1 K (+45.43 %) |
| Feb 23 2016 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 15.65 | 19,844 | 310,559 | 198,111 | 218 K to 198.1 K (-9.10 %) |
| Nov 24 2015 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 17.17 | 934 | 16,037 | 217,955 | 218.9 K to 218 K (-0.43 %) |
| Aug 24 2015 | TBPH | Theravance Biophar ... | Mammen Mathai | SVP, Research & Dev ... | Payment of Exercise | F | 12.98 | 934 | 12,123 | 218,889 | 219.8 K to 218.9 K (-0.42 %) |